English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
University of Edinburgh
Trending
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Sarepta to seek full FDA approval for Duchenne therapies after failed confirmatory trial
+
Regulatory
Patient Daily
| Mar 30, 2026
Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+
Pharmaceuticals
Patient Daily
| Mar 25, 2026
Lilly reports late-stage diabetes data for triple-G agonist retatrutide
No Results
